Q1 2026 · 13F-HR
HARBOURVEST PARTNERS LLCholdings as filed
Filed 2026-05-15 · accession 0001193125-26-225130
$100.9M
Reported value
5
Positions
2026-03-31
Period end
The Brief · HARBOURVEST PARTNERS LLC · Q1 2026
AI · grounded in 13F
HARBOURVEST PARTNERS LLC established a new position in Generate Biomedicines GENB valued at $21.5M. The fund closed three positions, most notably exiting Rubrik, Inc. RBRK for $6.9M. Other liquidated holdings included Epsilon Energy LTD EPSN at $3.9M and Repare Therapeutics, Inc. RPTX at $31.9K.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G5279N105 | KLAR | Klarna Group PLC | $65.8M | 65.2% | 5,023,320 | Common | SOLE |
| 370920100 | GENB | Generate Biomedicines | $21.5M | 21.3% | 1,722,210 | Common | SOLE |
| 35969L108 | YMM | Full Truck Alliance Co. Ltd. | $7.9M | 7.88% | 957,580 | Common | SOLE |
| 13463J101 | CAMP | CAMP4 Therapeutics Corp | $5.6M | 5.56% | 1,271,948 | Common | SOLE |
| 15673T100 | IPSC | Century Therapeutics, Inc. | $65,581 | 0.06% | 29,018 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.